Proof-of-Concept Phase-2a Clinical Trial of Etokimab (Anti-IL-33 Antibody) in the Treatment of Severe Eosinophilic Asthma
June 5, 2019
Londei et al., 2019 June. Presented at the 2019 European Academy of Allergy and Clinical Immunology (EAACI) Congress.